Search Results - "BREUX, J. P"

Refine Results
  1. 1

    Opportunistic infections occurring during highly active antiretroviral treatment by MICHELET, C, ARVIEUX, C, CARTIER, F, FRANCOIS, C, BESNIER, J. M, ROGEZ, J. P, BREUX, J. P, SOUALA, F, ALLAVENA, C, RAFFI, F, GARRE, M

    Published in AIDS (London) (01-10-1998)
    “…To analyse the characteristics of opportunistic infections in patients receiving highly active antiretroviral treatment (HAART). A retrospective study…”
    Get full text
    Journal Article
  2. 2

    Francisella tularensis aortitis by Briere, M., Kaladji, A., Douane, F., Breux, J. P., Touroult-Jupin, P., Boisset, S., Edouard, S., Biron, C., Boutoille, D.

    Published in Infection (01-04-2016)
    “…Francisella tularensis , the agent of tularemia, is a Gram-negative coccobacillus primarily pathogen for animals and occasionally for humans. The clinical…”
    Get full text
    Journal Article
  3. 3

    Retrospective study of 108 cases of botulism in Poitiers, France by Roblot, P, Roblot, F, Fauchere, J. L, Devilleger, A, Marechaud, R, Breux, J. P, Grollier, G, Becq-Giraudon, B

    Published in Journal of medical microbiology (01-06-1994)
    “…1 Service de Médecine Interne et Maladies Infectieuses, 350 Avenue Jacques Coeur, 86021 Poitiers Cedex, France * Laboratoire de Microbiologie A, Hôpital La…”
    Get full text
    Journal Article
  4. 4

    Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis by SILVAIN, C, BOUQUET, S, BREUX, J. P, BECQ-GIRAUDON, B, BEAUCHANT, M

    Published in European journal of clinical pharmacology (01-01-1989)
    “…Plasma and ascitic fluid concentrations of ofloxacin were determined in 12 cirrhotic patients after a single dose and repeated 200 mg oral doses. The single…”
    Get full text
    Journal Article
  5. 5

    The VIRGO study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults by Raffi, F, Reliquet, V, Ferré, V, Arvieux, C, Hascoet, C, Bellein, V, Besnier, J M, Breux, J P, Garré, M, May, T, Molina, J M, Perré, P, Raguin, G, Rozenbaum, W, Zucman, D

    Published in Antiviral therapy (01-12-2000)
    “…The virological and immunological efficacy of the triple regimen containing nevirapine (once or twice daily), didanosine (once daily) and stavudine, in…”
    Get full text
    Journal Article
  6. 6

    Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis by CARDEY, J, SILVAIN, C, BOUQUET, S, BREUX, J. P, BECQ-GIRAUDON, B, FOURTILLAN, J. P, BEAUCHANT, M

    Published in European journal of clinical pharmacology (01-01-1987)
    “…Plasma and ascitic fluid concentrations of pefloxacin in 10 cirrhotic patients and 8 healthy volunteers were determined following administration of a single…”
    Get full text
    Journal Article
  7. 7

    Stimulation of peripheral blood lymphocytes of HIV-infected patients by jacalin, a lectin mitogenic for human CD4+ lymphocytes by Pineau, N, Brugier, J C, Breux, J P, Becq-Giraudon, B, Descamps, J M, Aucouturier, P, Preud'homme, J L

    Published in AIDS (London) (01-10-1989)
    “…The proliferative response of peripheral blood mononuclear cells stimulated by jacalin was investigated in 157 samples from 104 HIV-infected patients at…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10

    Central Venous Catheter-related Infection Due to Comamonas testosteroni in a Woman With Breast Cancer by LE MOAL, Gwénaël, PACCALIN, Marc, BREUX, Jean-Philippe, ROBLOT, France, ROBLOT, Pascal, BECQ-GIRAUDON, Bertrand

    “…A 75-y-old woman with breast cancer presented with bacteremia due to Comamonas testosteroni. Evolution was favorable following adapted antimicrobial therapy…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients by Reliquet, V, Ferré, V, Hascoet, C, Besnier, J M, Bellein, V, Arvieux, C, Molina, J M, Breux, J P, Zucman, D, Rozenbaum, W, Allavena, C, Raffi, F

    Published in Antiviral therapy (1999)
    “…In an ongoing, open-label, non-comparative study, the safety and efficacy of nevirapine/stavudine/didanosine were evaluated in 100 antiretroviral-naive adults…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Discontinuing Prophylaxis against Pneumocystis carinii Pneumonia by Bender, M A, Sax, P E

    Published in The New England journal of medicine (24-05-2001)
    “…To the Editor: In his editorial (Jan. 18 issue) 1 accompanying two studies 2 , 3 demonstrating the safety of discontinuing prophylaxis against Pneumocystis…”
    Get full text
    Journal Article
  16. 16

    Attitude of the clinican toward adverse effects of protease inhibitors by Nicol, B, Champagne, X, Breux, J P, Pasdeloup, T, Remblier, C, Pérault, M C, Vandel, B

    Published in Therapie (01-09-2000)
    “…Since 1996, marketing of new drugs called protease inhibitors has revolutionized the treatment of patients suffering from AIDS. The side-effects of this new…”
    Get more information
    Journal Article
  17. 17

    Stavudine plus didanosine and nevirapine in antiretroviral-naive HIV-infected adults: preliminary safety and efficacy results. VIRGO Study Team by Raffi, F, Reliquet, V, Francois, C, Garre, M, Hascoet, C, Allavena, C, Arvieux, C, Breux, J P, Perre, P, Rozenbaum, W, Auger, S

    Published in Antiviral therapy (1998)
    “…The objective of this open-label trial is to evaluate the virological and immunological effects of triple therapy with stavudine (40 mg twice daily if > or =…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20

    Cognitive evoked potentials and HIV infection by Gil, R, Breux, J P, Neau, J P, Becq-Giraudon, B

    Published in Neurophysiologie clinique (01-11-1992)
    “…Endogenous event-related potentials (and especially the P300 component) have delayed latencies relative to normal controls in patients with dementias of…”
    Get more information
    Journal Article